Erreger Microbicidal effectiveness of povidone-iodine (Betaisodona®) against highly resistant gram positives;Antibakterielle Wirksamkeit von Polyvidon-lod (Betaisodona®) auf hochresistente grampositive

Zentralblatt fur Hygiene und Umweltmedizin

Volumn 200, Issue 5-6, 1998, Pages 435-442

  Wichelhaus, Thomas A ^a   Schäfer, Volker ^a   Hunfeld, Klaus Peter ^a   Reimer, Karen ^b   Fleischer, Wolfgang ^b   Brade, Volker ^b  

^a GOETHE UNIVERSITY   (Germany)

^b MUNDIPHARMA GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROCOCCUS FAECIUM; GENETICS; GRAM POSITIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIA; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POVIDONE-IODINE; STAPHYLOCOCCUS AUREUS;

EID: 0031991227     PISSN: 09348859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aihara, M., M.Sakai, M. Iwasaki, K.Shimakawa, S.Kozaki, M.Kubo, M.Jyohki, H. Takahasi, and J. Yamamoto: Prevention and control of nosocomial infection caused by methicillin-resistant Staphylococcus aureus in a premature infant ward preventive effect of a povidone-iodine wipe of neonatal skin. Postgrad. Med. J. 69 Suppl.3 (1993) 117-121
2. Berkelmann, R. L., B. W. Holland, and R. L. Anderson: Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J. Clin. Microbiol. 15 (1982) 635-639
3. Cookson, B. D., R. W. Lacey, W. C. Noble, D. S. Reeves, R. Wise, and R.J. Redhead: Mupirocin-resistant Staphylococcus aureus. Lancet 1 (1990) 1095-1096
4. Duckwortb, G.J.: Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ. 307 (1993) 1049-1052
5. Eltringham, L: Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 35 (1997) 1-8
6. Görtz, G., K. Reimer und H. Neef: Entwicklung, Eigenschaften und Bedeutung von PVP-Jod. In: Topische Infektionstherapie und Prophylaxe. Hrsg. Hierholzer, G., K. Reimer und E. R. Weissenbacher, S. 3-7, Georg Thieme Verlag, Stuttgart (1996)
7. Gottardi, W.: Iodine and iodine compounds. In: Disinfection, Sterilization and Preservation. Hrsg. Block, S.S., 4th Edition, S. 152-166, Lea & Febiger, Philadelphia (1991)
8. Heuck, D., C. Braulke, H. Lauf und W. Witte: Analysen und Schlufolgerungen zur epidemischen Ausbreitung von Methicillin-resistenten S. aureus. Zbl. Hyg. 198 (1995) 57-71
9. Hingst, V., K. M. Klippel und H. G. Sonntag: Untersuchungen zur Epidemiologie mikrobieller Biozidresistenzen. Zbl. Hyg. 197 (1995) 232-251
10. W.Kobayashi, H., M.Tsuzuki, and K. Hosobuchi: Bactericidal effects of antiseptics and disinfectants against methicillin-resistant Staphylococcus aureus. Infect. Control. Hosp. Epidemiol. 10 (1989) 562-564
11. Koppensteiner, G.: Die antimikrobielle Wirkung von PVP-Jod. In: PVP-Jod in der operativen Medizin. Hrsg. Hierholzer, G. und G. Görtz, S. 34-39, Springer Verlag, Berlin (1984)
12. Lacey, R. W. and A. Catto: Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad. Med. J. 69, Suppl. 3 (1993) 78-83
13. Layton, M. C. andJ. E. Patterson: Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital. Antimicrob. Agents Chemother. 38 (1994) 1664-1667
14. Masano, H., K.Fukuchi, R. Wakuta, and Y. Tanaka: Efficacy of intranasal application of povidone-iodine cream in eradicating nasal methicillin-resistant Staphylococcus aureus in neonatal intensive care unit (NICU) staff. Postgrad. Med. J. 69 Suppl. 3 (1993) 122-125
15. McLure, A. R. and J. Gordon: In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 21 (1992) 291-299
16. Michel, M. and L. Gutmann: Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 349 (1997) 1901-1906
17. Rahn, R.: Review presentation on povidone-iodine antisepsis in the oral cavity. Postgrad. Med. J. 69 (1993) 4-9
18. Rahn, R., M. Ghahremani und V.Schäfer: Keimreduzierende Wirkung verschiedener Mundantiseptika - Untersuchungen in vivo. Z. Stomatol. 91 (1994) 155-160
19. Schneider, C., M. Weindel, and V. Brade: Frequency, clonal heterogeneity and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) isolated in 1992-1994. Zbl. Bakteriol. 283 (1996) 529-542
20. Schubert, R.: Disinfectant properties of new povidone-iodine preparations. J. Hosp. Infect. 6 Suppl. (1985) 33-36
21. Shiraishi, T. and Y. Nakagawa: Review of disinfectant susceptibility of bacteria isolated in hospital to commonly used disinfectants. Postgrad. Med. J. 69, Suppl. 3 (1993) 70-77
22. Wenzel, R. P. and T. M. Perl: The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect. 31 (1995) 13-24
23. Werner, H. P.: Microbicidal Effectiveness of selected Antiseptics. Hyg. Med. 17 (1992) 51-59